ANN-ROBERT CROSBY: Open Payments
NPI 1649971441 · FRANKLIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 46 payments from 11 companies in 2025. Trend: 2023 $866 · 2024 $951 · 2025 $933
Food & beverage: $820Education: $113
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $257 |
| GENZYME CORPORATION | 5 | $207 |
| Novartis Pharmaceuticals Corporation | 5 | $106 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $100 |
| UCB, Inc. | 4 | $84 |
| ABBVIE INC. | 3 | $70 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Incyte Corporation | 1 | $25 |
| Amgen Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
Products named: TREMFYA, DUPIXENT, Bimzelx, COSENTYX, RINVOQ, NEMLUVIO, SKYRIZI, OPZELURA.
Industry payments across TN — which companies pay providers there.
